穿孔性胃潰瘍的管理:你需要知道的
Samir Rasslan1, Raul Coimbra, Roberto Rasslan
1From the Division of General Surgery and Trauma (S.R., R.R., E.M.U.), Faculdade de Medicina da Universidade de São Paulo, Brazil; Division of Acute Care Surgery and Comparative Effectiveness and Clinical Outcomes Research Center (CECORC) (R.C.), Riverside University Health System Medical Center, Moreno Valley; and Loma Linda University School of Medicine (R.C.), Loma Linda, California.
穿孔性胃潰瘍是一種嚴重的合併症,儘管醫學進步,仍需要迅速的手術介入. 早期诊断和立即手术对于改善这些高风险患者的治疗结果至关重要.
科学领域:
- 胃肠病学 胃肠病学
- 外科胃肠道外科手术
- 临床外科 临床外科
背景情况:
- 胃潰瘍疾病 (PUD) 仍然普遍存在,影響全球數百萬人.
- 虽然医疗管理是有效的,但并发症仍然发生在10-20%的病例中.
- 穿孔性胃潰瘍是最常見的手術指標,也是PUD死亡率的主要原因.
研究的目的:
- 分析穿孔性胃潰瘍治療的各種方面.
- 为了确定穿孔性胃潰瘍的最佳治療策略.
- 突出早期诊断和手术干预的重要性.
主要方法:
- 关于穿孔性胃潰瘍管理的最新文獻的回顧.
- 分析影响治疗成功的因素.
- 评估不同的外科手术方法及其结果.
主要成果:
- 穿孔是PUD的一个关键并发症,导致显著的发病率和死亡率.
- 早期诊断和及时的手术干预是成功治疗的关键决定因素.
- 现在手术治疗主要用于PUD并发症,如穿孔.
结论:
- 穿孔性胃需要紧急的外科治疗.
- 优化治疗包括早期检测和及时的手术干预.
- 对管理这种外科紧急情况的最佳做法进行进一步的研究是有必要的.
相关概念视频
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Esophageal Perforation-II: Clinical Manifestations and Management
Clinical Manifestations:
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...


